IP Library Granted Patent US 7,727,629
Granted Patent B2
US 7,727,629 · App. 10/891,776 · Granted Jun 1, 2010

Encapsulated agglomeration of microcapsules and method for the preparation thereof

Assignee: Ocean Nutrition Canada Limited
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,727,629
App. No.
10/891,776
Granted
Jun 1, 2010
Kind
B2
Abstract

Microcapsules comprising an agglomeration of primary microcapsules, each individual primary microcapsule having a primary shell and the agglomeration being encapsulated by an outer shell, may be prepared by providing an aqueous mixture of a loading substance and a shell material, adjusting pH, temperature, concentration and/or mixing speed to form primary shells of shell material around the loading substance and cooling the aqueous mixture until the primary shells agglomerate and an outer shell of shell material forms around the agglomeration. Such microcapsules are useful for storing a substance and for delivering the substance to a desired environment.

Claims (17)

1. A method for delivering a loading substance to a subject, comprising administering to the subject a microcapsule comprising an agglomeration of primary microcapsules, each individual primary microcapsule having a primary shell and the agglomeration being encapsulated by an outer shell, wherein the loading substance is encapsulated in the primary microcapsule,

wherein the loading substance comprises omega-3 fatty acids, derivatives thereof, or mixtures thereof;

wherein the primary shell and the outer shell are each formed from a complex coacervate of a two component system;

wherein the microcapsule is crosslinked with an enzymatic crosslinker; and

wherein the loading substance is from 60% to 70% by weight of the microcapsule.

2. The method of claim 1 , wherein the enzymatic crosslinker is transglutaminase.

3. The method of claim 1 , wherein the outer shell has an average diameter of from about 50 μm to about 100 μm.

4. The method of claim 1 , wherein the outer shell has an average diameter of from about 20 μm to about 100 μm.

5. The method of claim 1 , wherein the primary shell has an average diameter of from about 40 nm to about 10 μm.

6. The method of claim 1 , wherein the primary shell has an average diameter of from about 0.1 μm to about 5 μm.

7. The method of claim 1 , wherein the primary shell has an average diameter of from about 1 μm to about 5 μm.

8. The method of claim 1 , wherein the primary shell has an average diameter of about 1 μm.

9. The method of claim 1 , wherein the two-component system is made from gelatin type A and polyphosphate.

10. The method of claim 1 , wherein the microcapsule is spray dried.

11. The method of claim 1 , wherein the subject is a mammal.

12. The method of claim 1 , wherein the subject is a human.

13. The method of claim 1 , wherein the microcapsule further comprises ascorbic acid or a salt thereof

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Sep 19, 2013
From: OCEAN NUTRITION CANADA LIMITED
To: DSM NUTRITIONAL PRODUCTS AG
Reel/Frame 031246/0134 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 26, 2013
From: YAN, NIANXI
To: OCEAN NUTRITION CANADA LIMITED
Reel/Frame 030291/0274 →
Continuity (2)
Continuation 1012062100 · Apr 11, 2002
Related Publication 20050019416A1 · Jan 27, 2005